Crow’s Feet Market

Market Overview:

The 7 major crow’s feet markets are expected to exhibit a CAGR of 2.69% during 2024-2034.

The crow’s feet market has been comprehensively analyzed in IMARC's new report titled "Crow’s Feet Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Crow’s feet, medically known as periocular wrinkles, are a cosmetic concern that affects the skin around the eyes. These fine lines and wrinkles typically appear as a person ages due to the natural breakdown of collagen and elastin, along with repeated facial expressions, such as smiling and squinting. The symptoms of the illness include the development of small, crinkly lines extending from the corners of the eyes, resembling the feet of a crow when the face is animated. As time passes, these lines can deepen and become more noticeable, causing patients to feel self-conscious about their appearance. The diagnosis of crow’s feet is straightforward and usually based on a visual examination. Dermatologists or qualified healthcare professionals can easily make a diagnosis by identifying the distinctive wrinkles and their characteristic patterns associated with the disease. Additionally, a history of sun exposure, lifestyle habits, and genetics may also be taken into account during the evaluation process.

The expanding geriatric population, who are prone to age-related decline in the amount of collagen and elastin in the skin, is primarily driving the crow’s feet market. In addition to this, the increasing cases of genetic alterations that lead to the overactivity of certain signaling pathways, resulting in the progressive development of wrinkles and fine lines around the outer corners of the eyes, are also creating a positive outlook for the market. Moreover, the widespread adoption of effective non-invasive procedures, such as botulinum toxin injections, dermal fillers, retinoid creams, etc., is further bolstering the market growth. These interventions help in reducing muscle contractions, restoring lost volume, and promoting collagen synthesis, thus minimizing the appearance of fine lines in individuals suffering from the ailment. Apart from this, the escalating application of advanced skincare products and formulations enriched with antioxidants, peptides, and hyaluronic acid, since they offer anti-aging benefits by improving skin elasticity and decreasing the depth of wrinkles, is acting as another significant growth-inducing factor. Additionally, the emerging popularity of laser therapies, such as intense pulsed light (IPL) and fractional laser resurfacing treatments, which target specific areas of skin damage to promote more youthful-looking skin, is expected to drive the crow’s feet market during the forecast period.

IMARC Group's new report provides an exhaustive analysis of the crow’s feet market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report the United States has the largest patient pool for crow’s feet and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario and unmet medical needs, etc. have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the crow’s feet market in any manner.

Time Period of the Study

•  Base Year: 2023
• Historical Period: 2018-2023
• Market Forecast: 2024-2034
   

Countries Covered

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
   

Analysis Covered Across Each Country

• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the crow’s feet market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the crow’s feet market
• Reimbursement scenario in the market
• In-market and pipeline drugs

Competitive Landscape:

This report also provides a detailed analysis of the current crow’s feet marketed drugs and late-stage pipeline drugs.

In-Market Drugs

• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance    
   

Late-Stage Pipeline Drugs

• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance

Key Questions Answered in this Report:

Market Insights

• How has the crow’s feet market performed so far and how will it perform in the coming years?
• What are the markets shares of various therapeutic segments in 2023 and how are they expected to perform till 2034?
• What was the country-wise size of the crow’s feet market across the seven major markets in 2023 and what will it look like in 2034?
• What is the growth rate of the crow’s feet market across the seven major markets and what will be the expected growth over the next ten years?
• What are the key unmet needs in the market?
   

Epidemiology Insights

• What is the number of prevalent cases (2018-2034) of crow’s feet across the seven major markets?
• What is the number of prevalent cases (2018-2034) of crow’s feet by age across the seven major markets?
• What is the number of prevalent cases (2018-2034) of crow’s feet by gender across the seven major markets?
• How many patients are diagnosed (2018-2034) with crow’s feet across the seven major markets?
• What is the size of the crow’s feet patient pool (2018-2023) across the seven major markets?
• What would be the forecasted patient pool (2024-2034) across the seven major markets?
• What are the key factors driving the epidemiological trend of crow’s feet?
• What will be the growth rate of patients across the seven major markets?
   

Crow’s Feet: Current Treatment Scenario, Marketed Drugs and Emerging Therapies

• What are the current marketed drugs and what are their market performance?
• What are the key pipeline drugs and how are they expected to perform in the coming years?
• How safe are the current marketed drugs and what are their efficacies?
• How safe are the late-stage pipeline drugs and what are their efficacies?
• What are the current treatment guidelines for crow’s feet drugs across the seven major markets?
• Who are the key companies in the market and what are their market shares?
• What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the crow’s feet market?
• What are the key regulatory events related to the crow’s feet market?
• What is the structure of clinical trial landscape by status related to the crow’s feet market?
• What is the structure of clinical trial landscape by phase related to the crow’s feet market?
• What is the structure of clinical trial landscape by route of administration related to the crow’s feet market?